Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Ulta Beauty (ULTA)

Ulta Beauty names Christopher DelOrefice as CFO, effective December 5, 2025

Neutral Impact 4 of 5 leadership Written later

Ulta Beauty appointed Christopher DelOrefice, currently EVP and CFO of Becton Dickinson, as its Chief Financial Officer, effective December 5, 2025. Chris Lialios, who has been serving as interim CFO, will return to his former role of Senior Vice President, Controller. A CFO change is a significant leadership event for shareholders, and the filing sets out his pay package, including a $1,000,000 sign-on cash payment and $3,300,000 in restricted stock units.

Key points

  • Christopher DelOrefice, 54, named CFO effective December 5, 2025; previously EVP and CFO of Becton Dickinson since September 2021
  • Base salary of $980,000; target annual cash incentive of 125% of base salary, maximum 200% of target
  • Sign-on cash payment of $1,000,000 plus restricted stock units valued at $1,100,000 and $2,200,000, subject to vesting schedules
  • Christopher Lialios returns to Senior Vice President, Controller after serving as interim CFO

The filing

CompanyUlta Beauty (ULTA)
Form8-K, current report
Filed with the SECOct 16, 2025, 9:00 AM ET
Accession number0001104659-25-099926

Items reported: 5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 16, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.